Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Summit

ORNL shreds 250 petabytes of disk drives from the Summit supercomputer — Alpine storage system dismantled in preparation for the world's fastest supercomputer

The Alpine storage system, a high-performance storage array for the world's 9th fastest supercomputer, has shredded all of its drives by ORNL in preparation for its replacement, Alpine2, which will power Summit until November.

Tom’s Hardware

$200 million supercomputer will be scrapped within weeks — ORNL's Summit could be a bargain for someone with very deep pockets, lofty ambitions (and some serious real estate to park it all)

ORNL's Summit supercomputer is going to be scrapped in weeks

TechRadar

How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery

BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Up 1,123% YTD, Is It Too Late to Buy This Breakout Biotech Stock?

Summit Therapeutics is a clinical-stage biotech company that has returned over 1,100% in 2024. Is the stock still a good buy right now?

Barchart

Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale

Summit Therapeutics stock rocketed again Thursday — adding onto an 85% gain this week — after raising $235 million in a private placement.

Investors Business Daily

Adam Smith: The voice of boxing on beating cancer in the fight of his life

Smith, the commentator whose voice has been called ‘synonymous with boxing’, speaks to Alex Pattle about his absence from the sport – and his welcome return

The Independent UK

Merck Dives After Summit — Up 56% — Sneaks In With Keytruda-Walloping Punch

Merck stock tumbled Monday after Summit Therapeutics' cancer drug outperformed blockbuster Keytruda in a study of lung cancer patients.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Is It Finally Time to Blow Up the Pay TV Bundle Once and For All?

Also in this week's 'Next Text,' we ponder what the Internet has taken from us ... as we look to surrender to AI

Broadcasting & Cable

China's Growing Influence In Africa Summit

China's growing influence in Africa highlighted at Beijing summit, focusing on economic partnerships and political alignment.

Top News

Snag This Russell 2000 Stock Now for 'Soft Landing' Upside

Amid rising hopes for an economic soft landing, analysts believe this Russell 2000 stock is poised to shine.

Barchart

Got a Hot Rate on a Money Market Account? Think Again

After taxes and inflation, the real return you get may not be as good as you think. Here's another approach to consider: fixed deferred annuities.

Kiplinger

‘I am devastated and furious’: 12 actors controversially recast in films, from Johnny Depp to Rachel Weisz

THE COUNTDOWN: From salary disputes and poor scripts to feuds and voiceovers that apparently sound ‘too old’, Hollywood is filled with stories of emergency recastings due to off-screen conflicts, writes Adam White

The Independent UK

One Retiree's Story of How She Built Her Retirement Nest Egg

One way to build wealth is to max out your company’s retirement plans, but doing it in tax-efficient ways can make an even bigger difference.

Kiplinger

Biofuel groups envision ethanol-powered jets. But fueling the effort has not been easy

Farming and biofuels organizations are hopeful that ethanol could be used to power passenger jets, but making that dream a reality hasn’t been easy

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Tom’s Guide

You can make a non-toxic mosquito trap in 7 easy steps — here's how

While we love the summer months for sunshine and being out in our yards, mosquitoes also love it too. Here's how to create a mosquito larvae trap that will help you tackle the buzzing and biting pests.

Tom’s Guide

Strava's new Family Plan membership will launch this year — what does it include and is it worth it?

With Strava set to roll out a Family Plan subscription option later this year, is it worth upgrading your account? Here’s the pros and cons.

Coach

Baby Jogger Summit X3 Running Stroller Review

The Baby Jogger Summit X3 is a sturdy running stroller that can handle trails as well as the road

USA Today Sports Media Group

How to buy Summit League men’s basketball conference tournament tickets

Want to watch Summit League men's basketball conference tournament in person on March 8-12? Tickets still remain for as little as $21.

Get all your
news in one place.

100’s of premium titles.
One news app.

Motor1

2024 Jeep Grand Cherokee Is Up To $4,595 Cheaper Than Before

In a rare twist, the newer version of a car is actually cheaper than its predecessor.

Kiplinger

2024 Investment Outlook: Three Tips for the New Year

What should investors do to protect their nest eggs as we head into a presidential election and face continued uncertainty about interest rates?

GoodToKnow

Baby Jogger Summit X3 Stroller Review

Reader, it's true. It folds with one hand. And our tester's baby napped during her run.

Tom’s Guide

I wore these Sketchers Slip-ins for a week of workouts — here's my verdict

A review of the Skechers Slip-ins Summits shoes - here's what happened when we tested them for a week of workout

Evening Standard

Key questions ahead of Rishi Sunak's AI safety summit

AI leaders are hoping the government will tone down its focus on extreme scenarios

The Independent UK

Major Navigator CO2 pipeline project is on hold while the company reevaluates the route in 5 states

One of the two biggest proposed carbon dioxide pipeline projects in the Midwest is being put on hold so the company can reevaluate the route

Fortune

The PE firm making billions off the Klaviyo IPO only 4 years after investing

Summit Partners used the newly-opened IPO market to cash in.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.